Articles From: Covanta Holding Corporation to Present at J.P. Morgan Global High Yield & Leveraged Finance Conference to Covidien Reports Second-Quarter Results


2013/2/25
http://media.marketwire.com/attachments/201302/131046_CovantaLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=989932&ProfileId=051205&sourceType=1 MORRISTOWN, NJ --
Sign-up for Covanta Holding Corporation to Present at J.P. Morgan Global High Yield & Leveraged Finance Conference investment picks
2013/2/28
http://media.marketwire.com/attachments/201302/132580_CovantaLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=991718&ProfileId=051205&sourceType=1 MORRISTOWN, NJ --
Sign-up for Covanta Holding Corporation to Present at Raymond James' 34th Annual Institutional Investors Conference investment picks
2013/3/7
http://media.marketwire.com/attachments/201203/24280_CovantaLogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=994413&ProfileId=051205&sourceType=1 MORRISTOWN, NJ --
Sign-up for Covanta Increases Quarterly Cash Dividend Payout by 10 Percent investment picks
2013/4/24
CHATTANOOGA, Tenn., April 24, 2013 (GLOBE NEWSWIRE) -- Covenant Transportation Group, Inc. (Nasdaq:CVTI) announced today financial and operating results for the first quarter ended March 31, 2013.
Sign-up for Covenant Transportation Group Announces First Quarter Financial and Operating Results investment picks
2013/2/11
CHATTANOOGA, Tenn.
Sign-up for Covenant Transportation Group, Inc. Announces Participation In BB&T And Stifel Nicolaus Conferences investment picks
2013/4/18
CHATTANOOGA, Tenn., April 18, 2013 (GLOBE NEWSWIRE) -- Covenant Transportation Group, Inc. (Nasdaq:CVTI) announced it plans to release its first quarter earnings in the late afternoon on Wednesday, April 24.
Sign-up for Covenant Transportation Group, Inc. Announces Timing of First Quarter Earnings Release and Conference Call investment picks
2013/3/4
Coventry Health Care Inc. is ranked third in the health insurance and managed care category of FORTUNE magazine’s list of “World’s Most Admired Companies” for 2013.
Sign-up for Coventry Health Care Ranked Among FORTUNE’s List of World’s Most Admired Companies investment picks
2013/5/1
Coventry Health Care, Inc. (NYSE: CVH) today reported consolidated operating results for the quarter ended March 31, 2013.
Sign-up for Coventry Health Care Reports First Quarter Earnings investment picks
2013/4/22
Coventry Health Care, Inc. (NYSE: CVH) announced today that it will release first quarter 2013 financial results before the market opens on Wednesday, May 1, 2013, unless the previously announced transaction with Aetna closes before May 1, 2013.
Sign-up for Coventry Health Care Schedules Release of First Quarter 2013 Financial Results investment picks
2013/4/26
Covidien PLC (COV) fiscal second-quarter earnings fell 12% as restructuring costs and other items masked the health- care products company's improved sales.
Sign-up for Covidien 2nd-Quarter Net Falls 12% on Charges; Sales Up investment picks
2013/5/8
Covidien (NYSE: COV) , a leading global provider of healthcare products, will present at the Bank of America Merrill Lynch 2013 Health Care Conference in Las Vegas, NV, on Wednesday, May 15, 2013.
Sign-up for Covidien and Mallinckrodt to Present at Bank of America Merrill Lynch Conference investment picks
2013/4/11
Covidien (NYSE: COV) , a leading global provider of healthcare products, today announced an agreement with VIDA Diagnostics, a pioneer in quantitative pulmonary imaging analysis software.
Sign-up for Covidien and VIDA Diagnostics Collaborate to Expand Minimally Invasive Treatment of Lung Disease investment picks
2013/5/3
Covidien (NYSE: COV) , a leading global provider of healthcare products, today announced revised 2013 guidance and released historical financial statements adjusted for the upcoming expected discontinued operations, reflecting the planned spin-off of its Pharmaceuticals business.
Sign-up for Covidien Announces 2013 Guidance and Provides Historical Financial Statements Adjusted for Discontinued Operations investment picks
2013/2/1
Covidien plc (NYSE: COV) today announced the initial filing by Mallinckrodt plc of a Form 10 Registration Statement with the U.S. Securities and Exchange Commission (SEC) in connection with Covidien’s previously announced plan to spin off its Pharmaceuticals business.
Sign-up for Covidien Announces Filing of Form 10 Registration Statement in Connection with Planned Spin-Off of Pharmaceuticals Business investment picks
2013/5/3
Covidien (NYSE:COV) today announced 2013 full year guidance for Mallinckrodt plc as Mallinckrodt prepares to spin off from Covidien to become a separate, publicly traded company in mid-2013.
Sign-up for Covidien Announces First Full-Year Outlook for Mallinckrodt plc investment picks
2013/3/15
Covidien (NYSE:COV) today announced nominees to the future board of directors of Mallinckrodt plc as Mallinckrodt prepares to become a separate, independently traded company in mid-2013.
Sign-up for Covidien Announces Nominees to Board of Directors for Mallinckrodt Pharmaceutical Business investment picks
2013/5/13
Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), priced an underwritten offering of $750 million aggregate principal amount of 2.950% senior notes due 2023.
Sign-up for Covidien Announces Pricing of $750 Million Senior Notes Offering investment picks
2013/3/20
Covidien plc (NYSE: COV) announced the results from today’s Annual General Meeting.
Sign-up for Covidien Announces Results from 2013 Annual General Meeting investment picks
2013/5/13
Covidien plc (NYSE: COV) today announced that its wholly-owned subsidiary, Covidien International Finance S.A. (CIFSA), launched an underwritten offering of senior notes.
Sign-up for Covidien Announces Senior Notes Offering investment picks
2013/5/6
Covidien (NYSE: COV) , a leading global provider of healthcare products, today announced the appointment of Jacqueline Strayer as Senior Vice President, Corporate Communications, effective immediately.
Sign-up for Covidien Appoints Jacqueline Strayer Senior Vice President, Corporate Communications investment picks
2013/3/29
Covidien (NYSE: COV) , a leading global provider of healthcare products, today announced that it has won a patent infringement suit against Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, relating to Ethicon's Harmonic® line of ultrasonic surgical products.
Sign-up for Covidien Awarded $176.5 Million Verdict in Patent Litigation against Ethicon Endo-Surgery investment picks
2013/2/20
Covidien (NYSE: COV) , a leading global provider of healthcare products, today announced the completion of patient enrollment in its iliac stent clinical study series.
Sign-up for Covidien Completes Patient Enrollment in Iliac Stent Clinical Study Series investment picks
2013/5/3
Covidien PLC (COV) has reduced its full-year net sales guidance after factoring in the impending spinoff of its pharmaceuticals business, while adjusting its financial statements for the past three years.
Sign-up for Covidien Cuts Sales View to Reflect Segment Divestiture investment picks
2013/3/21
Covidien plc (NYSE: COV) today announced that its Board of Directors has authorized a new program to purchase up to $3 billion of the Company’s ordinary shares from time to time, based on market conditions.
Sign-up for Covidien Expands Share Repurchase Program and Declares Quarterly Cash Dividend investment picks
2013/4/17
Covidien (NYSE: COV) , a leading global provider of healthcare products, is launching two new surgical access devices at the annual meeting of the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), which starts today.
Sign-up for Covidien Introduces New Surgical Access Devices at SAGES 2013 investment picks
2013/4/15
Covidien (NYSE: COV) , a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today added a new product to its family of Shiley TM neonatal and pediatric tracheostomy tubes.
Sign-up for Covidien Launches New Shiley™ Neonatal and Pediatric Tracheostomy Tubes investment picks
2013/3/13
Covidien (NYSE:COV) , a leading global provider of healthcare products, is launching three new hernia care products that address clinical needs in laparoscopic inguinal, ventral and umbilical hernia repair.
Sign-up for Covidien Launches Three New Hernia Care Products at American Hernia Society Annual Meeting investment picks
2013/3/14
Covidien plc (NYSE: COV) will report second-quarter results on April 26, 2013, before trading begins.
Sign-up for Covidien plc to Report Second-Quarter Results on April 26, 2013 investment picks
2013/4/26
Covidien plc (NYSE: COV) today reported results for the second quarter of fiscal 2013 (January - March 2013). Second-quarter net sales of $3.10 billion increased 5% from the $2.95 billion reported in the second quarter a year ago.
Sign-up for Covidien Reports Second-Quarter Results investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Covanta Holding Corporation to Present at J.P. Morgan Global High Yield & Leveraged Finance Conference to Covidien Reports Second-Quarter Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity